Cytodyn Inc (CYDY)

[chumppunk]

Follow a couple name drops from CC. Merck, Viiv, Glaxo along with "partnering potential" being mentioned and it's clear why upping the dose to achieve +90% HIV success is clear. And throw in Pestells take on current chemo-combo meds failures.
Maraviroc, Keytruda, Selzentry (all from these companies for oncology and HIV) have serious side effects, liver, hormone gland,organ failures etc. Their success rate not close to Pro-140 trials now at 70% with NO SIDE EFFECTS. But they are making tons of cash now.
I don't see Pro 140 as a threat to them but an opportunity once CYDY closes their deal and secures both oncology and HIV use of Pro 140 under one roof.
CYDY's Pro-140 for HIV and Pestells oncology patents and potential Pro 140 oncology applications are in limbo pending the acquisition close.

My point is after acquisition closing... Pro-140 for HIV or oncology makes them a bigger market target for partnership or buy out.
Just a few weeks!
Chump